author-photo

Timothy M Illidge

National Institutes of Health

5

Papers

18

Citations

Citation Trend

Filter By

Papers (3) Sort By

Journal Conference Others

Phase 1/2a study of 177Lu-lilotomab satetraxetan in relapsed/refractory indolent non-Hodgkin lymphoma.

2020 Blood Advances
Show All
- Source
- Cite
- Save
Citations (3)
RESPONSE TO A+CHP BY CD30 EXPRESSION IN THE ECHELON-2 TRIAL

2019 Hematological Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Maximum tumor diameter is associated with event-free survival in PET-negative patients with stage I/IIA Hodgkin lymphoma

2019 Blood Advances
Show All
- Source
- Cite
- Save
Citations (7)